Cargando…

SURG-11. Surgery for control of brain metastases after prior checkpoint inhibitor immunotherapy: a single-center series

BACKGROUND: Despite the promising results for treating metastatic cancer with checkpoint inhibitor immunotherapies, there are limited data on surgical outcomes for brain metastases (BMs) that have progressed after prior checkpoint inhibitor treatment. The objective of this study was to identify fact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morshed, Ramin, Chung, Jason, Sudhakar, Vivek, Cummins, Daniel, Young, Jacob, Hervey-Jumper, Shawn, Theodosopoulos, Philip, Aghi, Manish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351241/ http://dx.doi.org/10.1093/noajnl/vdab071.104

Ejemplares similares

12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT
por: Morshed, Ramin, et al.
Publicado: (2020)

LOCL-06 SUPERVISED MACHINE LEARNING IDENTIFIES RISK FACTORS ASSOCIATED WITH LEPTOMENINGEAL DISEASE AFTER SURGICAL RESECTION OF BRAIN METASTASES
por: Morshed, Ramin, et al.
Publicado: (2022)

CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases
por: Morshed, Ramin A, et al.
Publicado: (2023)

Sarcopenia Diagnosed Using Masseter Muscle Diameter as a Survival Correlate in Elderly Patients with Glioblastoma
por: Morshed, Ramin A., et al.
Publicado: (2022)

Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2023)

Surgical advances in the management of brain metastases
por: Ng, Patrick R, et al.
Publicado: (2021)

OTEH-11. Single Cell RNA Sequencing to identify cellular heterogeneity with in Pituitary Adenomas
por: Jain, Saket, et al.
Publicado: (2021)

SURG-14. Laser Ablation for Brain Metastases: Risk Factors for Neurologic Complication
por: Pawloski, Jacob, et al.
Publicado: (2021)

SURG-13. Multiplicity does not affect outcomes in patients with surgically treated brain metastases
por: Yang, Kaiyun, et al.
Publicado: (2021)

SURG-10. The evolving role of neurosurgery for central nervous system metastases in the era of personalized medicine
por: Karschnia, Philipp, et al.
Publicado: (2021)

Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology
por: Pekmezci, Melike, et al.
Publicado: (2021)

Emergent immunotherapy approaches for brain metastases
por: Wang, Jianbo, et al.
Publicado: (2021)

SURG-06. Metastases in the pineal region: a systematic review of clinical features, treatment strategies and survival outcomes
por: Palmisciano, Paolo, et al.
Publicado: (2021)

Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature
por: Morshed, Ramin A., et al.
Publicado: (2021)

SURG-05. Neurosurgery for brain metastases from non-small cell lung cancer: survival outcome and prognostic factors
por: Li, De-pei, et al.
Publicado: (2021)

Immunotherapy Resistance in Glioblastoma
por: Wang, Elaina J., et al.
Publicado: (2021)

SURG-03. The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes
por: Newman, William, et al.
Publicado: (2021)

Novel intraoperative strategies for enhancing tumor control: Future directions
por: Haddad, Alexander F, et al.
Publicado: (2022)

31. RADIATION NECROSIS IN STEREOTACTIC RADIOSURGERY AND CHECKPOINTS INHIBITORS FOR BRAIN METASTASES FROM LUNG ADENOCARCINOMA
por: Jurica, James, et al.
Publicado: (2020)

CLRM-11 CURRENT STATE OF CLINICAL TRIALS FOR PATIENTS WITH MELANOMA BRAIN METASTASES
por: Elghawy, Omar, et al.
Publicado: (2022)

72. THE COMBINED USE OF STEROIDS AND IMMUNE CHECKPOINT INHIBITORS IN BRAIN METASTASES PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Jessurun, Charissa, et al.
Publicado: (2020)

MET-11 Recent advances in targeted therapies and immunotherapy for metastatic brain tumors
por: Ando, Yuichi
Publicado: (2021)

32. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING AMINO ACID PET IN PATIENTS WITH BRAIN METASTASES
por: Galldiks, Norbert, et al.
Publicado: (2020)

11. ASSOCIATION OF TUMOR EXPOSURE TO CEREBROSPINAL FLUID SPACES TO LEPTOMENINGEAL DISEASE IN PATIENTS WITH BRAIN METASTASES
por: Patel, Kunal, et al.
Publicado: (2020)

MMAP-10 ADVERSE RADIATION EFFECT AFTER STEREOTACTIC RADIOSURGERY AND IMMUNOTHERAPY/TARGETED THERAPY FOR MELANOMA BRAIN METASTASES
por: Phuong, Christina, et al.
Publicado: (2022)

SURG-09. Benefits of laser interstitial thermal therapy in the treatment of biopsy-proven radiation necrosis
por: Lerner, Emily, et al.
Publicado: (2021)

MMAP-07 IMPACT OF SINGLE AND DUAL IMMUNE CHECKPOINT BLOCKADE ON RISK OF RADIATION NECROSIS AMONG PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY
por: Vaios, Eugene, et al.
Publicado: (2022)

ETMM-09 TARGETING GLIOBLASTOMA MULTIFORME METABOLISM AT THE INVASIVE TUMOR FRONT
por: Garcia, Joseph H, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Neurosurgical Transfers: A Single Tertiary Center Study
por: Reihl, Sheantel J., et al.
Publicado: (2022)

MMAP-11 VOLUMETRIC STUDY OF BRAIN METASTASES IN EGFR-POSITIVE NSCLC TREATED WITH OSIMERTINIB WITH OR WITHOUT CNS-DIRECTED RADIATION THERAPY
por: Ni, Lisa, et al.
Publicado: (2022)

73. PREDICTION OF A SECOND LOCAL RECURRENCE IN SURGICALLY TREATED RECURRENT BRAIN METASTASES PATIENTS
por: Tewarie, Ishaan, et al.
Publicado: (2020)

SURG-08. Laser Interstitial Thermal Therapy (LITT) versus Resection in the Treatment of Lesions In or Near the Primary Motor Cortex
por: Srinivasan, Ethan, et al.
Publicado: (2021)

SYST-09 IMPACT OF END-STAGE RENAL DISEASE AND CONCOMITANT DIALYSIS ON THE EFFICACY OF IMMUNOTHERAPY IN BRAIN METASTASES PATIENTS: A PROPENSITY-MATCHED SURVIVAL ANALYSIS
por: Baroz, Angel, et al.
Publicado: (2022)

SURG-07. Plasmonic gold nanostars to increase the efficiency and specificity of laser interstitial thermal therapy (LITT) in the treatment of brain tumors
por: Srinivasan, Ethan, et al.
Publicado: (2021)

SURG-04. Surgical resection of symptomatic brain metastasis in patients with non-small cell lung cancer irrespective from lesion count
por: Jünger, Stephanie T, et al.
Publicado: (2021)

75. PROGRAMMED DEATH RECEPTOR LIGAND ONE EXPRESSION MAY INDEPENDENTLY PREDICT SURVIVAL IN NON-SMALL CELL LUNG CARCINOMA BRAIN METASTASES PATIENTS RECEIVING IMMUNOTHERAPY
por: Hulsbergen, Alexander, et al.
Publicado: (2020)

Abstracts from Rambam Research Day, December 11, 2014
Publicado: (2015)

Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022)

48. DEVELOPING TUMOR-HOMING CYTOTOXIC HUMAN INDUCED NEURAL STEM CELLS AS AN ADJUVANT TREATMENT FOR RADIATION THERAPY OF BRAIN METASTASES
por: Mercer-Smith, Alison, et al.
Publicado: (2020)

Toxicities associated with checkpoint inhibitors—an overview
por: Spiers, Laura, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nsmgpd4in645m98vf1srqjpkq2